Healius Future Growth

Future criteria checks 3/6

Healius's revenue is forecast to decline at 4.8% per annum while its annual earnings are expected to grow at 90.1% per year. EPS is expected to grow by 103.8% per annum. Return on equity is forecast to be 2.3% in 3 years.

Key information

90.1%

Earnings growth rate

103.8%

EPS growth rate

Healthcare earnings growth24.1%
Revenue growth rate-4.8%
Future return on equity2.3%
Analyst coverage

Good

Last updated04 Dec 2024

Recent future growth updates

Recent updates

Is Healius Limited (ASX:HLS) Trading At A 50% Discount?

Mar 15
Is Healius Limited (ASX:HLS) Trading At A 50% Discount?

At AU$3.07, Is It Time To Put Healius Limited (ASX:HLS) On Your Watch List?

Feb 06
At AU$3.07, Is It Time To Put Healius Limited (ASX:HLS) On Your Watch List?

Here's Why Healius (ASX:HLS) Can Manage Its Debt Responsibly

Dec 02
Here's Why Healius (ASX:HLS) Can Manage Its Debt Responsibly

Is Now An Opportune Moment To Examine Healius Limited (ASX:HLS)?

Oct 13
Is Now An Opportune Moment To Examine Healius Limited (ASX:HLS)?

Are Investors Undervaluing Healius Limited (ASX:HLS) By 48%?

Aug 02
Are Investors Undervaluing Healius Limited (ASX:HLS) By 48%?

Why Healius Limited (ASX:HLS) Could Be Worth Watching

May 23
Why Healius Limited (ASX:HLS) Could Be Worth Watching

Healius Limited's (ASX:HLS) Prospects Need A Boost To Lift Shares

Apr 02
Healius Limited's (ASX:HLS) Prospects Need A Boost To Lift Shares

Healius (ASX:HLS) Is Paying Out A Larger Dividend Than Last Year

Feb 25
Healius (ASX:HLS) Is Paying Out A Larger Dividend Than Last Year

Earnings and Revenue Growth Forecasts

ASX:HLS - Analysts future estimates and past financials data (AUD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/20271,465211622328
6/30/20261,398141442159
6/30/20251,6771952232827
6/30/20241,746-636203267N/A
12/31/20231,692-984217284N/A
9/30/20231,699-682237309N/A
6/30/20231,707-380257333N/A
12/31/20221,83935313407N/A
9/30/20222,064164403497N/A
6/30/20222,289292493587N/A
12/31/20212,292226549624N/A
9/30/20212,103146506575N/A
6/30/20211,91466464526N/A
3/31/20211,80275460512N/A
12/31/20201,69083456497N/A
9/30/20201,63083395452N/A
6/30/20201,57083333407N/A
12/31/20191,50211099233N/A
9/30/20191,5348349180N/A
6/30/20191,56657-2128N/A
3/31/20191,7852923140N/A
12/31/20181,752248153N/A
9/30/20181,728374177N/A
6/30/20181,705499202N/A
3/31/20181,694-256N/A215N/A
12/31/20171,683-516N/A227N/A
9/30/20171,671-516N/A220N/A
6/30/20171,659-517N/A212N/A
3/31/20171,648-260N/A219N/A
12/31/20161,637-3N/A227N/A
9/30/20161,63918N/A256N/A
6/30/20161,64238N/A285N/A
12/31/20151,595126N/A270N/A
9/30/20151,587121N/A255N/A
6/30/20151,580117N/A239N/A
3/31/20151,596127N/A256N/A
12/31/20141,572118N/A271N/A
9/30/20141,548116N/A266N/A
6/30/20141,524115N/A261N/A
3/31/20141,501134N/A256N/A
12/31/20131,478131N/A243N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: HLS is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).

Earnings vs Market: HLS is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: HLS is expected to become profitable in the next 3 years.

Revenue vs Market: HLS's revenue is expected to decline over the next 3 years (-4.8% per year).

High Growth Revenue: HLS's revenue is forecast to decline over the next 3 years (-4.8% per year).


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: HLS's Return on Equity is forecast to be low in 3 years time (2.3%).


Discover growth companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 00:23
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Healius Limited is covered by 30 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Dennis HulmeAPP Securities Pty Ltd.
Russell WrightBarclay Pearce Capital Pty Limited
Benjamin BrayshawBarrenjoey Markets Pty Limited